Department of Histology, Medical University of Gdańsk, Gdańsk, Poland.
Steroids. 2011 Jan;76(1-2):193-203. doi: 10.1016/j.steroids.2010.10.009. Epub 2010 Nov 9.
We have synthesized 3β,21-dihydroxypregna-5,7-dien-20-one (21(OH) 7DHP) and used UVB radiation to induce its photoconversion to analogues of vitamin D (pD), lumisterol (pL) and tachysterol (pT). The number and character of the products and the dynamics of the process were dependent on the UVB dose. The main products: pD and pT compounds were characterized by UV absorption, MS and NMR spectroscopy after RP-HPLC chromatography. In addition, formation of multiple oxidized derivatives of the primary products was detected and one of these derivatives was characterized as oxidized 21-hydroxyisotachysterol compound (21(OH)oxy-piT). These newly synthesized compounds inhibited growth of human melanoma cells in a dose dependent manner, with greater or equal potency to calcitriol. 3β,21-Dihydroxy-9β,10α-pregna-5,7-dien-20-one (21(OH)pL) and 21(OH)oxy-piT had higher potency against pigmented melanoma cells, while the EC(50) for compounds 21(OH)7DHP and (5Z,7E)-3β,21-dihydroxy-9,10-secopregna-5,7,10(19)-trien-20-one (21(OH)pD) were similar in both pigmented and non-pigmented cells. Moreover, 21(OH)7DHP and its derivatives inhibited proliferation of human epidermal HaCaT keratinocytes, albeit at a lower activity compared to melanoma cells. Importantly, 21(OH)7DHP derivatives strongly inhibited the colony formation of human melanoma cells with 21(OH)pD being the most potent. The potential mechanism of action of newly synthesized compounds was similar to that mediated by 1,25(OH)(2)D(3) and involved ligand-induced translocation of vitamin D receptor into the nucleus. In summary, we have characterized for the first time products of UVB-induced conversion of 21(OH)7DHP and documented that these compounds have selective, inhibitory effects on melanoma cells.
我们合成了 3β,21-二羟孕甾-5,7-二烯-20-酮(21(OH)7DHP),并用 UVB 辐射诱导其光转化为维生素 D 的类似物(pD)、lumisterol(pL)和 tachysterol(pT)。产物的数量和特征以及过程的动力学取决于 UVB 剂量。主要产物:pD 和 pT 化合物通过反相高效液相色谱(RP-HPLC)色谱后用 UV 吸收、MS 和 NMR 光谱进行了表征。此外,还检测到初级产物的多个氧化衍生物的形成,其中一种衍生物被表征为氧化 21-羟异他卡醇化合物(21(OH)oxy-piT)。这些新合成的化合物以剂量依赖的方式抑制人黑色素瘤细胞的生长,其效力与 calcitriol 相当。3β,21-二羟基-9β,10α-孕甾-5,7-二烯-20-酮(21(OH)pL)和 21(OH)oxy-piT 对色素性黑色素瘤细胞的活性更高,而化合物 21(OH)7DHP 和 (5Z,7E)-3β,21-二羟基-9,10-seco 孕甾-5,7,10(19)-三烯-20-酮(21(OH)pD)的 EC50 在色素性和非色素性细胞中相似。此外,21(OH)7DHP 及其衍生物抑制人表皮 HaCaT 角质形成细胞的增殖,尽管其活性低于黑色素瘤细胞。重要的是,21(OH)7DHP 衍生物强烈抑制人黑色素瘤细胞的集落形成,其中 21(OH)pD 最为有效。新合成化合物的潜在作用机制与 1,25(OH)2D3 介导的机制相似,涉及配体诱导维生素 D 受体向核内易位。总之,我们首次表征了 UVB 诱导的 21(OH)7DHP 转化产物,并证明这些化合物对黑色素瘤细胞具有选择性抑制作用。